Centro de Pesquisas René Rachou/FIOCRUZ Minas, Belo Horizonte, MG, Brazil.
Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
PLoS One. 2020 May 7;15(5):e0232786. doi: 10.1371/journal.pone.0232786. eCollection 2020.
A low proportion of P. vivax-exposed individuals acquire protective strain-transcending neutralizing IgG antibodies that are able to block the interaction between the Duffy binding protein II (DBPII) and its erythrocyte-specific invasion receptor. In a recent study, a novel surface-engineered DBPII-based vaccine termed DEKnull-2, whose antibody response target conserved DBPII epitopes, was able to induce broadly binding-inhibitory IgG antibodies (BIAbs) that inhibit P. vivax reticulocyte invasion. Toward the development of DEKnull-2 as an effective P. vivax blood-stage vaccine, we investigate the relationship between naturally acquired DBPII-specific IgM response and the profile of IgG antibodies/BIAbs activity over time.
METHODOLOGY/PRINCIPAL FINDINGS: A nine-year follow-up study was carried-out among long-term P. vivax-exposed Amazonian individuals and included six cross-sectional surveys at periods of high and low malaria transmission. DBPII immune responses associated with either strain-specific (Sal1, natural DBPII variant circulating in the study area) or conserved epitopes (DEKnull-2) were monitored by conventional serology (ELISA-detected IgM and IgG antibodies), with IgG BIAbs activity evaluated by functional assays (in vitro inhibition of DBPII-erythrocyte binding). The results showed a tendency of IgM antibodies toward Sal1-specific response; the profile of Sal1 over DEKnull-2 was not associated with acute malaria and sustained throughout the observation period. The low malaria incidence in two consecutive years allowed us to demonstrate that variant-specific IgG (but not IgM) antibodies waned over time, which resulted in IgG skewed to the DEKnull-2 response. A persistent DBPII-specific IgM response was not associated with the presence (or absence) of broadly neutralizing IgG antibody response.
CONCLUSIONS/SIGNIFICANCE: The current study demonstrates that long-term exposure to low and unstable levels of P. vivax transmission led to a sustained DBPII-specific IgM response against variant-specific epitopes, while sustained IgG responses are skewed to conserved epitopes. Further studies should investigate on the role of a stable and persistent IgM antibody response in the immune response mediated by DBPII.
低比例的间日疟原虫暴露个体获得能阻断血影蛋白结合蛋白 II(DBPII)与其红细胞特异性入侵受体相互作用的具有菌株跨越中和能力的 IgG 抗体。在最近的一项研究中,一种新型表面工程化的 DBPII 为基础的疫苗,称为 DEKnull-2,其抗体反应的目标是保守的 DBPII 表位,能够诱导广泛结合抑制性 IgG 抗体(BIAbs),抑制间日疟原虫网织红细胞入侵。为了将 DEKnull-2 开发为一种有效的间日疟原虫血期疫苗,我们研究了自然获得的 DBPII 特异性 IgM 反应与 IgG 抗体/BIAbs 活性随时间的变化关系。
方法/主要发现:对长期间日疟原虫暴露的亚马逊个体进行了为期九年的随访研究,包括在高和低疟疾传播期进行的六次横断面调查。通过常规血清学(ELISA 检测的 IgM 和 IgG 抗体)监测与菌株特异性(Sal1,在研究地区循环的天然 DBPII 变体)或保守表位(DEKnull-2)相关的 DBPII 免疫反应,并通过功能测定(体外抑制 DBPII-红细胞结合)评估 IgG BIAbs 活性。结果显示,IgM 抗体对 Sal1 特异性反应有倾向;Sal1 对 DEKnull-2 的模式与急性疟疾无关,并持续整个观察期。连续两年低疟疾发病率使我们能够证明,变体特异性 IgG(但不是 IgM)抗体随时间推移而减弱,导致 IgG 向 DEKnull-2 反应倾斜。持续的 DBPII 特异性 IgM 反应与广泛中和 IgG 抗体反应的存在(或不存在)无关。
结论/意义:本研究表明,长期低水平和不稳定的间日疟原虫传播导致对变体特异性表位的持续 DBPII 特异性 IgM 反应,而持续的 IgG 反应则偏向保守表位。进一步的研究应探讨稳定和持续的 IgM 抗体反应在 DBPII 介导的免疫反应中的作用。